期刊文献+

不同剂量氟伐他汀对冠心病患者内皮素、白细胞介素-6和脂联素水平的影响 被引量:2

The effects of different doses of fluvastatin on ET-I,IL-6 and APN in patients with coronary heart disease
原文传递
导出
摘要 目的探讨不同剂量氟伐他汀对冠心病患者内皮素(ET-1)、白细胞介素-6(IL-6)和脂联素(APN)水平的影响。方法选择80例冠心病患者并按数字表法随机平分为两组各40例:分别为氟伐他汀40mg和80mg治疗组;另外选择∞例健康体检者作为对照组。测定治疗前后ET-1、IL-6和APN浓度。结果治疗前40mg和80mg治疗组患者血清ET-1、IL-6水平高于对照组(t=4.755、4.342、4.567,4.696,均P〈0.05),血清APN水平低于对照组(t=4.133、4.278,P〈0.05);两组治疗后血清ET.1、IL-6水平均有明显下降,血清APN水平明显升高(t=4.012、4.213、4.332、4.576、4.969、4.578,均P〈0.05),但80mg治疗组更为显著(t=3.558、3.332、3.911,均P〈0.05)。结论冠心病患者的血清ET-1、IL.6水平升高,APN降低,氟伐他汀可能通过降低ET-1、IL-6,升高APN水平而发挥抗炎作用,其作用与药物剂量有关。 Objective To explore the influence of different doses of fluvastatin on endothelin 1 (ET-1) ,in- terleukin 6 (IL-6) and adiponectin (APN) levels in patients with coronary heart disease(CHD). Methods 80 pa- tients with CHD were randomly divided into fluvastatin 40rag group and fluvastatin 80mg group, 40 cases in each group. And 30 healthy persons were selected as control group. Serum levels of ET-1 ,IL-6 and APN were measured be- fore and after treatment. Results Before treatment, serum levels of ET-1 and IL-6 in fluvastatin group were signifi- cantly higher than control group( t = 4. 755,4. 342,4. 567,4. 696, all P 〈 0.05 ), serum level of APN was significantly lower than the control group ( t = 4.133,4. 278, P 〈 0.05 ). After treatment, the serum levels of ET-land IL-6 were sig- nificantly decreasd, serum level of APN was significantly increasd in fluvastatin 40mg group and fluvastatin 80mg group( t = 4. 012,4.213,4.332,4. 576,4. 969,4. 578, all P 〈 0.05 ). The effect of fluvastatin 80mg group was signifi- cantly better than fluvastatin 40mg group ( t = 3. 558,3. 332,3.911, all P 〈 0.05 ). Conclusion Serum levels of ET-1 and IL-6 increase, APN decreases in CHD patients. Fluvastatin has anti-inflammatory effect through decreasing ET-1 and IL-6,increasing APN, and its effect is related to the drug dose.
作者 张柏源
出处 《中国基层医药》 CAS 2013年第23期3553-3554,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 冠状动脉疾病 内皮素-1 白细胞介素6 脂联素 氟伐他汀 Coronary diseases Endothelin-1 Interleukin-6 Adiponectin Fluvastatin
  • 相关文献

参考文献10

二级参考文献82

  • 1刘军,陈影,刘芳,姚庆姑,许火根,澎名淑,郭瑜琳,陈钦达.2型糖尿病家系非糖尿病一级亲属脂联素水平与胰岛素抵抗和动脉粥样硬化相关性研究[J].中华内分泌代谢杂志,2004,20(3):215-216. 被引量:30
  • 2[1]Izzo JL Jr, levy D, Black HR. Importance of systolic blood pressure in older Americans[J ]. Hypertension,2000,35: 1021 - 1024
  • 3[2]Aton JD, Wentworth D. for the Multiple Risk Factor intervention trial research group. Serum cholesterol,blood pressure, cigarette smoking, and dearth from coronary heart disease: overall findings and differences byage for 316099 white men[J]. Arch Intern Med,1992,152: 56 - 64
  • 4[3]Franlin SS, Khan SA, Wong ND, et al. Is pulse pressure useful in predicting risk for coronary heart disease?The Framingham Heart Study[J ]. Circulation, 1999,100: 354 - 360
  • 5[4]National high blood pressure education program working group report on hypertension in the elderly. National high blood pressure education program working group[ J ]. Hypertension, 1994,23: 275 - 285
  • 6[5]Franklin SS, Jacobs MJ, Wong ND. Predominance of isolated systolic hypertension among middle- age and elderly US hypertensives: analysis based on National Health and Nutrition Examination survey (NHANES)Ⅲ [J ]. Hypertension, 2001,37: 869 - 874
  • 7[6]SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older patients with isolated systolic hypertension [ J ]. JAMA, 1991,265: 3255 - 3264
  • 8[7]Kostis JB. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension: the SHEP Cooperative Research Group[ J ]. JAMA, 1997,278: 212 - 216
  • 9[8]Staessen JA. for The systolic hypertension in Europe(Sys- Eur) trial investigators. Randomized doubleblind comparison of placebo and active treatment for older patients with isolated systolic hypertension [J ].Lancet, 1997,350: 757 - 764
  • 10[9]Staessen J A, Gasowski J, Wang J G, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta - analysis of outcome trials [ J ]. Lancet,2000,355: 865 - 872

共引文献444

同被引文献31

  • 1曹广超,王立祥.氟伐他汀联合贝那普利治疗老年糖尿病肾病患者的疗效及作用机制[J].中国老年学杂志,2014,34(8):2032-2033. 被引量:9
  • 2刘海琴.氟伐他汀治疗老年糖尿病肾病39例[J].中国老年学杂志,2014,34(7):1989-1990. 被引量:2
  • 3中华医学会心血管病学分会.2007中国慢性心力衰竭诊断治疗指南.中华心血管病杂志,2007,.
  • 4孙宇姣,齐国先,高远,等.不同负荷方案阿托伐他汀对经皮冠状动脉介入治疗的急性冠状动脉综合征的疗效[J].中华心血管病杂志,2011,39(9):45-46.
  • 5Mega C, de Lemos ET, Vala H, et al. Diabetic Nephropathy Amel- ioration by a Low-Dose Sitagliptin in an Animal Model of Type 2 Diabetes (Zucker Diabetic Fatty Rat) [ J ]. Exp Diabetes Res, 2011,16(20) :92.
  • 6Eric D, Kristian T, Samantha H, et al. Interpreting discordant in- direct and multiple treatment comparison meta-analyses:an evalu- ation of direct acting antivirals for chronic hepatitis C infection [ J ]. Clinical epidemiology ,2013,5 ( 5 ) : 173-183.
  • 7Hunziker S, Hugle T, Schuchardt K, et al. The value of serum pro- calcitonin level for differentiation of infections from noninfectious causes of fever after orthopedic surgery [ J ]. Bone Joint Surg, 2010,92( 1 ) :138-148.
  • 8Schuetz P, Christ-Crain M, Huber AR, et al. Long-term stability of procalcitonin in frozen samples and comparison of Kryptor ( R ) and VIDAS ( R ) automated immunoassays [ J ]. Clin Biochem, 2009,43 (3) : 341-344.
  • 9Fitzpatrick DC, Sheerin DV, Wolf BR, et al. A randomized, pro- spective study comparing intertrochanterlc hip fracture fixation with the dynamic hip screw and the dynamic helical hip system in a community practice [ J ]. Iowa Orthop J,2011,31 ( 2 ) : 166 -172.
  • 10Cheng T,Zhang G,Zhang X. Review: Minimally invasive versus conventional dynamic hip screw fixation in elderly patients with intertrochanteric fractures : a systematic review and meta-analysis [J]. Surg Innov,2011,18(2) :99-105.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部